Skip to content
Disclosery

GILEAD SCIENCES, INC.: ACLX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of GILEAD SCIENCES, INC. on ACLX, newest first. How the timeline and the estimate are built.

GILEAD SCIENCES, INC. held 0 ACLX shares at 2026-06-30 per its 13F-HR filed 2026-08-03.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 0 shares
    Change vs previous 13F -6,720,803 shares

    13F-HR 0001123292-26-001034 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2026-03-31
    13F 6,720,803 shares
    Change vs previous 13F 0 shares

    36.44% of the 13F portfolio, value $771,682,600.

    13F-HR 0001123292-26-000642 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 6,720,803 shares
    Change vs previous 13F 0 shares

    22.64% of the 13F portfolio, value $438,196,356.

    13F-HR 0001123292-26-000164 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 6,720,803 shares
    Change vs previous 13F 0 shares

    30.8% of the 13F portfolio, value $551,777,926.

    13F-HR 0001123292-25-000642 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 6,720,803 shares
    Change vs previous 13F 0 shares

    34.57% of the 13F portfolio, value $442,564,878.

    13F-HR 0001123292-25-000364 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 6,720,803 shares
    Change vs previous 13F 0 shares

    37.32% of the 13F portfolio, value $440,884,677.

    13F-HR 0001123292-25-000217 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 6,720,803 shares
    Change vs previous 13F not available

    33.23% of the 13F portfolio, value $515,418,382.

    13F-HR 0001123292-25-000079 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).